Aimei Health Technology Co., Ltd. financial data

Symbol
AFJK, AFJKR, AFJKU on Nasdaq
Industry
Blank Checks
Location
10 East 53 Rd Street, Suite 3001, New York, NY
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 67.8 %
Debt-to-equity -127 %
Return On Equity -323 %
Return On Assets 3.52 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.12M shares -32.2%
Common Stock, Shares, Outstanding 2.13M shares 0%
Entity Public Float 71.4M USD
Common Stock, Value, Issued 213 USD 0%

Income Statement

Label TTM Value / Value Unit Change %
Nonoperating Income (Expense) 3.62M USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 2.55M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 30.4K USD -94.8%
Assets 73.8M USD +4.75%
Accrued Liabilities, Current 300K USD +1106%
Liabilities, Current 817K USD +3189%
Liabilities 1.51M USD +111%
Retained Earnings (Accumulated Deficit) -1.48M USD -999%
Stockholders' Equity Attributable to Parent -1.48M USD -1001%
Liabilities and Equity 73.8M USD +4.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -167K USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 2.13M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -167K USD
Unrecognized Tax Benefits 0 USD